A new study released on Apr. 10 describes a polymerase chain reaction (PCR) technique that allows for the complete amplification of the human papillomavirus type 16 (HPV16) genome.
The research is significant because HPV16 is a double-stranded circular DNA virus with a genome size of approximately 7–8 kilobases, and its detection and analysis are important for genomic studies and potential clinical applications.
According to the study, researchers divided the HPV16 genome into two large fragments, each with overlapping regions exceeding 500 base pairs. They used nested primers in combination with two highly accurate DNA polymerases to optimize reaction conditions. The sensitivity of this method was tested using samples diluted from an initial concentration of 2,000 copies per microliter down to as low as 2 copies per microliter.
Results showed high sensitivity for detecting HPV16. The Thermo Fisher enzyme enabled effective amplification at very low concentrations, achieving success rates of 50% at 2 copies/µL and 75% at 20 copies/µL. In contrast, the Vazyme enzyme did not achieve successful amplification at these lower concentrations but performed reliably at higher sample concentrations (200 copies/µL or greater). Sequencing confirmed that amplified products matched expected sizes and demonstrated over 98% identity with reference sequences.
The authors say that this overlapping extension PCR method provides a strong technical basis for future genomic research involving HPV16, including whole-genome sequencing and variation analysis. They also note that their findings may help optimize nested PCR systems more broadly and serve as a reference point for other studies requiring long-fragment DNA amplification.
